Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endothelium | 1 | 2008 | 73 | 0.300 |
Why?
|
| Cell Communication | 1 | 2008 | 165 | 0.290 |
Why?
|
| Endothelial Cells | 3 | 2013 | 528 | 0.240 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 1007 | 0.240 |
Why?
|
| Signal Transduction | 3 | 2013 | 4524 | 0.190 |
Why?
|
| Aortic Valve | 1 | 2024 | 426 | 0.190 |
Why?
|
| Cell Lineage | 2 | 2013 | 348 | 0.160 |
Why?
|
| Stem Cells | 2 | 2013 | 713 | 0.140 |
Why?
|
| Genes, Reporter | 2 | 2009 | 385 | 0.140 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2015 | 47 | 0.120 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2015 | 52 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2013 | 53 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 59 | 0.110 |
Why?
|
| Receptor, Notch1 | 1 | 2013 | 67 | 0.110 |
Why?
|
| Endothelium, Lymphatic | 1 | 2013 | 10 | 0.110 |
Why?
|
| Aldehyde Oxidoreductases | 2 | 2013 | 19 | 0.110 |
Why?
|
| Tretinoin | 2 | 2013 | 117 | 0.100 |
Why?
|
| Regenerative Medicine | 1 | 2011 | 30 | 0.100 |
Why?
|
| Cell Differentiation | 3 | 2013 | 1935 | 0.090 |
Why?
|
| Endothelium, Vascular | 1 | 2013 | 514 | 0.090 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 541 | 0.080 |
Why?
|
| Genetic Techniques | 1 | 2009 | 102 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 1885 | 0.070 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2007 | 18 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2008 | 220 | 0.070 |
Why?
|
| Time Factors | 2 | 2024 | 6186 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 961 | 0.070 |
Why?
|
| Heterozygote | 1 | 2008 | 681 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 804 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2008 | 810 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2009 | 1354 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 1389 | 0.060 |
Why?
|
| Models, Biological | 1 | 2008 | 1438 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 2442 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 1703 | 0.050 |
Why?
|
| Neovascularization, Physiologic | 2 | 2013 | 210 | 0.050 |
Why?
|
| Reoperation | 1 | 2024 | 812 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 2580 | 0.040 |
Why?
|
| Aortic Valve Stenosis | 1 | 2024 | 322 | 0.040 |
Why?
|
| Animals | 5 | 2015 | 33911 | 0.040 |
Why?
|
| Mice | 3 | 2015 | 17646 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2024 | 999 | 0.040 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2024 | 1101 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 317 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 232 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2013 | 7 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2013 | 2321 | 0.030 |
Why?
|
| Embryo Culture Techniques | 1 | 2013 | 27 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2013 | 54 | 0.030 |
Why?
|
| Lac Operon | 1 | 2013 | 94 | 0.030 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2013 | 34 | 0.030 |
Why?
|
| Lentivirus | 1 | 2013 | 84 | 0.030 |
Why?
|
| Lymphangiogenesis | 1 | 2013 | 18 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 286 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 1073 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2024 | 2999 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 873 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2024 | 8117 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2011 | 76 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 172 | 0.020 |
Why?
|
| Risk Factors | 1 | 2024 | 9883 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 1998 | 0.020 |
Why?
|
| United States | 1 | 2024 | 10499 | 0.020 |
Why?
|
| Infant | 1 | 2024 | 12349 | 0.020 |
Why?
|
| Male | 3 | 2024 | 59687 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2009 | 184 | 0.020 |
Why?
|
| Humans | 6 | 2024 | 122517 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2009 | 166 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2024 | 12033 | 0.020 |
Why?
|
| Female | 3 | 2024 | 65064 | 0.020 |
Why?
|
| Transfection | 1 | 2009 | 1076 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2007 | 76 | 0.020 |
Why?
|
| K562 Cells | 1 | 2007 | 95 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2009 | 619 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2024 | 15906 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 669 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 669 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2013 | 3782 | 0.020 |
Why?
|
| Plasmids | 1 | 2007 | 516 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2009 | 973 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 1682 | 0.010 |
Why?
|
| Gene Expression | 1 | 2009 | 1592 | 0.010 |
Why?
|
| Cell Line | 1 | 2009 | 2787 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2013 | 2588 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 2798 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 3118 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 7123 | 0.010 |
Why?
|